LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-2.06%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.18B
AUM Growth
+$1.18B
(-0.2%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
357
New
34
Increased
31
Reduced
193
Closed
83
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$35.8M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
$33.7M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
$29.3M |
| 4 |
Pfizer
PFE
|
$17.4M |
| 5 |
Globe Life
GL
|
$9.97M |
Top Sells
| 1 |
Visa
V
|
$14.5M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$12M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
$10.6M |
| 4 |
BioNTech
BNTX
|
$10.1M |
| 5 |
Republic Services
RSG
|
$5.59M |
Sector Composition
| 1 | Healthcare | 41.98% |
| 2 | Financials | 15.26% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Technology | 7.74% |
| 5 | Industrials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alexandria Real Estate Equities
ARE
$14.1B
| $3.48M | 0.3% |
24,826
+952
| +4% | +$133K |
|
|
ANSS
77
DELISTED
Ansys
ANSS
| $3.46M | 0.29% |
15,589
-163
| -1% | -$36.1K |
|
78
Natera
NTRA
$23.1B
| $3.44M | 0.29% |
78,451
-13,498
| -15% | -$592K |
|
79
Micron Technology
MU
$133B
| $3.44M | 0.29% |
68,595
+24,873
| +57% | +$1.25M |
|
80
Intellia Therapeutics
NTLA
$1.22B
| $3.41M | 0.29% |
61,004
-4,312
| -7% | -$241K |
|
81
Coca-Cola
KO
$297B
| $3.39M | 0.29% |
60,557
+2,111
| +4% | +$118K |
|
82
Sangamo Therapeutics
SGMO
$157M
| $3.34M | 0.28% |
682,300
-96,469
| -12% | -$473K |
|
83
Yum China
YUMC
$16.4B
| $3.33M | 0.28% |
+70,393
| New | +$3.33M |
|
84
PepsiCo
PEP
$204B
| $3.22M | 0.27% |
19,706
-1,126
| -5% | -$184K |
|
85
NVIDIA
NVDA
$4.24T
| $3.21M | 0.27% |
26,414
-2,276
| -8% | -$276K |
|
86
Crown Holdings
CCK
$11.6B
| $3.2M | 0.27% |
39,447
-5,578
| -12% | -$452K |
|
87
Adobe
ADBE
$151B
| $3.19M | 0.27% |
11,596
+1,200
| +12% | +$330K |
|
88
Iovance Biotherapeutics
IOVA
$807M
| $3.14M | 0.27% |
327,926
-84,162
| -20% | -$806K |
|
89
Procter & Gamble
PG
$368B
| $3.12M | 0.26% |
24,725
-271
| -1% | -$34.2K |
|
90
Copart
CPRT
$47.2B
| $3.07M | 0.26% |
28,890
-16,065
| -36% | -$1.71M |
|
91
Sprouts Farmers Market
SFM
$13.7B
| $3.04M | 0.26% |
+109,462
| New | +$3.04M |
|
92
GoodRx Holdings
GDRX
$1.51B
| $3.01M | 0.26% |
645,086
-362,849
| -36% | -$1.69M |
|
93
Kura Oncology
KURA
$686M
| $2.98M | 0.25% |
218,366
-15,907
| -7% | -$217K |
|
94
Editas Medicine
EDIT
$231M
| $2.97M | 0.25% |
242,248
-17,584
| -7% | -$215K |
|
95
Teladoc Health
TDOC
$1.37B
| $2.84M | 0.24% |
111,820
-12,445
| -10% | -$316K |
|
96
Huazhu Hotels Group
HTHT
$11.3B
| $2.8M | 0.24% |
83,400
-76,428
| -48% | -$2.56M |
|
97
Allogene Therapeutics
ALLO
$251M
| $2.79M | 0.24% |
258,214
-47,039
| -15% | -$508K |
|
98
Exact Sciences
EXAS
$8.98B
| $2.71M | 0.23% |
83,468
-32,992
| -28% | -$1.07M |
|
99
Fate Therapeutics
FATE
$120M
| $2.7M | 0.23% |
120,479
-8,734
| -7% | -$196K |
|
100
Itaú Unibanco
ITUB
$77B
| $2.64M | 0.22% |
511,300
-338,700
| -40% | -$1.75M |
|